Pomelo Care has raised $92 million in Series C funding to expand its virtual care model beyond maternity into a broader platform supporting women’s and children’s health. The round was led by Stripes with backing from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel, valuing the company at $1.7 billion. Pomelo launched in 2021 with a virtual maternity care model designed to supplement traditional pregnancy care by proactively predicting and addressing risk factors, and it now offers services spanning reproductive care, pregnancy, pediatrics, hormonal health, and perimenopause and menopause, alongside longer-term preventive care and condition management. The company partners with health plans and employers and says it covers more than 25 million lives through those relationships.
Pomelo provides 24/7 virtual access to a multispecialty clinical team and uses data science to identify risk early, monitor patients continuously, and close gaps in care while coordinating with in-person providers. The company says its maternity model supports nearly 7% of all U.S. births and cites findings from four independent studies showing reductions in total care costs in a Medicaid population, lower NICU and ER utilization for both mothers and infants, and better follow-up care for depression.
Pomelo has presented claims-based outcomes at national scientific and medical conferences, including reported reductions in NICU length of stay, preterm births, and emergency room utilization, along with higher prenatal depression screening and follow-up rates. It recently launched a midlife care program focused on hormonal, metabolic, and mental health during perimenopause and menopause, reporting an 88% reduction in symptoms on the Menopause Rating Scale in 60 days and a productivity increase reported by 73% of participants.
